Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (151-160 of 272) with videos related to

Pageof 28
Sort By:
The Lancet. Digital Health|August 1, 2021
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective studyMarjorie G Zauderer, Axel Martin, Jacklynn Egger, et al.
Journal of the American College of Radiology : JACR|August 4, 2014
ACR Appropriateness Criteria non-invasive clinical staging of bronchogenic carcinomaJames G Ravenel, Kenneth E Rosenzweig, Jacobo Kirsch, et al.
Clinical Lung Cancer|November 26, 2015
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for SurveillanceDaniel E Spratt, Abraham J Wu, Victoria Adeseye, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant TumorsNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Plos One|August 4, 2017
Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumorsKathryn C Arbour, Jarushka Naidoo, Keith E Steele, et al.
Advances in Radiation Oncology|January 23, 2024
Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation TherapyXingzhe Li, Ellen Yorke, Andrew Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2026
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancerAntonin Levy, Cécile Le Péchoux, Bjørn Grønberg, et al.
Translational Lung Cancer Research|October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancerKevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
The Annals of Thoracic Surgery|May 29, 2018
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung CancerWhitney S Brandt, Wanpu Yan, Jonathan E Leeman, et al.
Pageof 28

Showing results (151-160 of 272) with videos related to

Sort By:
Pageof 28
The Lancet. Digital Health|August 1, 2021
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective studyMarjorie G Zauderer, Axel Martin, Jacklynn Egger, et al.
Journal of the American College of Radiology : JACR|August 4, 2014
ACR Appropriateness Criteria non-invasive clinical staging of bronchogenic carcinomaJames G Ravenel, Kenneth E Rosenzweig, Jacobo Kirsch, et al.
Clinical Lung Cancer|November 26, 2015
Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for SurveillanceDaniel E Spratt, Abraham J Wu, Victoria Adeseye, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant TumorsNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.
Plos One|August 4, 2017
Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumorsKathryn C Arbour, Jarushka Naidoo, Keith E Steele, et al.
Advances in Radiation Oncology|January 23, 2024
Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation TherapyXingzhe Li, Ellen Yorke, Andrew Jackson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2026
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancerAntonin Levy, Cécile Le Péchoux, Bjørn Grønberg, et al.
Translational Lung Cancer Research|October 24, 2025
Radiomic phenotypes of oligometastatic non-small cell lung cancerKevin M Boehm, Emily S Lebow, N Ari Wijetunga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2018
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineHedy L Kindler, Nofisat Ismaila, Samuel G Armato, et al.
The Annals of Thoracic Surgery|May 29, 2018
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung CancerWhitney S Brandt, Wanpu Yan, Jonathan E Leeman, et al.
Pageof 28